e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Monitoring lung function in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metabolic syndrome, systemic inflammation and Framingham risk score are independent risk factors for reduced lung function in healthy Korean adults
S.Y. Lim, J.U. Song, K.S. Jung (Seoul, Republic Of Korea)
Source:
Annual Congress 2013 –Monitoring lung function in airway diseases
Session:
Monitoring lung function in airway diseases
Session type:
Thematic Poster Session
Number:
794
Disease area:
Airway diseases, Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S.Y. Lim, J.U. Song, K.S. Jung (Seoul, Republic Of Korea). Metabolic syndrome, systemic inflammation and Framingham risk score are independent risk factors for reduced lung function in healthy Korean adults. Eur Respir J 2013; 42: Suppl. 57, 794
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Step-down ventilatory strategy in obesity hypoventilation syndrome (OHS) patients treated by home noninvasive ventilation (NIV)
Related content which might interest you:
Lung function impairment in adult asthma increases the risk of systemic inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Systemic inflammation and lung function in adulthood and their association with early life factors
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality
Source: Eur Respir J 2010; 36: 1002-1006
Year: 2010
Risk factors of abnormal lung function in children and adolescents – data from the LEAD (Lung, hEart, sociAl, boDy) Study
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018
Ventilatory function as predictor of cardio-metabolic markers of cardiovascular disease: 10 year follow-up in young adults
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Lung function in school age children with chronic lung disease of prematurity
Source: International Congress 2015 – New findings in paediatric respiratory physiology
Year: 2015
Early-onset transient asthma and impaired lung function in adolescence - preliminary data from the BAMSE cohort
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013
Functional and immunological abnormalities in patients with severe asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Coagulation activity increases with disease severity in patients with asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Association between lung function and subclinical atherosclerosis in overweight subjects
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011
Diseases associated with restrictive lung function impairment
Source: Eur Respir Mon; 2009: 43: 142–149
Year: 2009
Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia
Source: International Congress 2014 – ILDs 3
Year: 2014
The utility of HLA-DQB302 as a genetic marker to predict the effect of aspirin desensitization on lung function of patients with aspirin exacerbated respiratory disease
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Bronchial hyperreactivity in young children is an independent risk factor for later asthma
Source: International Congress 2015 – Paediatric asthma and allergy: epidemiology and risk factors
Year: 2015
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Metabolic syndrome in patients with COPD and their association with systemic inflammation
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Lung function, bronchial hyperresponsiveness (BHR) and metabolic risk factors in adults: Preliminary results from the gene environment interaction in respiratory disease (GEIRD) survey
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept